Personalized Therapy Selection and Expert Insights in Modern Hemophilia Care

With the expanding landscape of hemophilia treatments, selecting the most appropriate therapy requires a patient-centered approach. Clinicians consider factors such as disease severity, inhibitor status, bleeding history, lifestyle, comorbidities, and prior treatment responses when determining whether a patient may benefit from factor replacement, mimetics, or rebalancing agents. Individual preferences, adherence potential, and quality-of-life considerations also guide decision-making, ensuring therapy aligns with each patient’s needs. In closing reflections, our panelists emphasized the importance of integrating clinical trial data with real-world experience, leveraging multidisciplinary collaboration, and maintaining ongoing patient education. They highlighted that personalized therapy selection, vigilant monitoring, and proactive management of breakthrough bleeds or adverse events are key to optimizing outcomes. Collectively, these strategies represent a shift toward more individualized, effective, and patient-focused hemophilia care.